GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Evolutionary Genomics FNAM · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Evolutionary Genomics — daily FNAM Delayed
Market value
$1,332
Last close × shares
Volume
300
Shares, 30 Oct 2026

About Evolutionary Genomics

Its shares trade under the ticker FNAM. It has been listed since 3 March 2011. In the fiscal year to 31 December 2020, it reported revenue of $12,500 and a net loss of $1.7m. At that date it held total assets of $4.0m and shareholders' equity of −$1.8m.

Evolutionary Genomics, Inc. is a genomics research and development company, which engages in the identification and validation of genes. The company is headquartered in Castle Rock, Colorado. The company went IPO on 2011-03-03. The firm is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. The company uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The firm has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.

Figures and description from our data supplier, not checked against the company's own report.

More about Evolutionary Genomics →

Latest on Evolutionary Genomics

Our reporting

We have not reported on Evolutionary Genomics yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Evolutionary Genomics's ticker?

Evolutionary Genomics trades as FNAM on its US listing, under ISIN US30051F1012.

What was Evolutionary Genomics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.